Premium
P4–189: A pilot study of relaxation to reduce stress in AD
Author(s) -
Astell Arlene,
Tunnard Catherine,
Balfour David
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.1928
Subject(s) - anxiety , relaxation (psychology) , dementia , progressive muscle relaxation , intervention (counseling) , psychological intervention , medicine , crossover study , psychology , physical therapy , clinical psychology , psychiatry , disease , alternative medicine , pathology , placebo
depression (11.5%), eating behaviors (8%), apathy (7%) and nighttime behaviors (7%). Univariate analysis showed that none of the baseline characteristics predicted neuropsychiatric symptoms at follow-up, except for self reported depression (Mann-Whitney U 692, Z 2.4, p 0.02). Conclusions: Neuropsychiatric symptoms are prevalent in 37.9% of MCI patients. The symptom profile is similar to what others have found with irritability being the most often reported neuropsychiatric symptom. Baseline cognitive measures, (I)ADL status and vascular risk factors do not predict neuropsychiatric symptoms at follow-up while self reported depression does.